Intuitive Surgical, Inc. $ISRG Shares Sold by Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust

Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.2% during the third quarter, Holdings Channel reports. The fund owned 23,903 shares of the medical equipment provider’s stock after selling 5,686 shares during the quarter. Intuitive Surgical comprises 2.4% of Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust’s portfolio, making the stock its 18th biggest holding. Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust’s holdings in Intuitive Surgical were worth $9,720,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Jeppson Wealth Management LLC purchased a new stake in Intuitive Surgical during the 3rd quarter worth about $259,000. Investment Research Partners LLC purchased a new position in Intuitive Surgical in the 3rd quarter valued at about $207,000. Worth Financial Advisory Group LLC boosted its stake in shares of Intuitive Surgical by 32.2% during the 3rd quarter. Worth Financial Advisory Group LLC now owns 887 shares of the medical equipment provider’s stock worth $361,000 after purchasing an additional 216 shares during the last quarter. Trellis Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $98,000. Finally, Richards Merrill & Peterson Inc. boosted its stake in shares of Intuitive Surgical by 8.8% during the 3rd quarter. Richards Merrill & Peterson Inc. now owns 6,863 shares of the medical equipment provider’s stock worth $2,791,000 after purchasing an additional 553 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 72 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the completion of the transaction, the director owned 179 shares of the company’s stock, valued at $70,364.90. This represents a 28.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the executive vice president owned 5,320 shares in the company, valued at approximately $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,370 shares of company stock worth $4,891,989 in the last quarter. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. BNP Paribas Exane raised shares of Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. Stifel Nicolaus reduced their price objective on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Finally, UBS Group restated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $498.83.

Intuitive Surgical Trading Up 1.5%

Intuitive Surgical stock opened at $433.18 on Tuesday. The firm has a market capitalization of $153.03 billion, a P/E ratio of 49.62, a PEG ratio of 3.22 and a beta of 1.46. The stock has a fifty day moving average price of $392.22 and a 200 day moving average price of $409.24. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.